T Cell News and Research

Latest T Cell News and Research

EVG brings high-volume manufacturing process solutions to biotechnology and medical device market

EV Group, a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today announced that it is increasing its focus on bringing its high-volume manufacturing process solutions and services to the biotechnology and medical device market.

27 Sep 2016

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

27 Sep 2016

Researchers identify new immune cell that protects mice from lung infections during chemotherapy

St. Jude Children's Research Hospital investigators have identified a new form of an immune cell that protected mice from life-threatening lung infections under conditions that mimic cancer chemotherapy.

27 Sep 2016

Nanoparticle injections may help prevent cartilage degeneration in osteoarthritis patients

Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.

27 Sep 2016

Cross-disciplinary concepts may lead to effective, personalised cancer treatments

It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells.

27 Sep 2016

Increasing specific brain fats could be potential strategy for preventing epileptic seizures

Increasing the concentration of specific fats in the brain could suppress epileptic seizures. This is evident from ground-breaking research carried out by the research groups of Professor Patrik Verstreken and Professor Wim Versées.

26 Sep 2016

Research shows degenerative diseases affecting the retina may be treatable with gene therapy

Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss.

26 Sep 2016

University of Bonn researchers develop new method to combat complex brain tumors

Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months.

26 Sep 2016

$Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients$

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times when compared to conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

A new analysis of records in the Veteran's Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in recent years, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

The recent approval of pembrolizumab (Keytruda) in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) following progression on a platinum-based chemotherapy was a significant advancement for the disease.

26 Sep 2016

Salk scientist Clodagh O'Shea named recipient of grant from Faculty Scholars Program

Clodagh O'Shea, an associate professor in the Salk Institute's Molecular and Cell Biology Laboratory, is among the first recipients of a grant from the Faculty Scholars Program, a new partnership of Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation and the Simons Foundation for early career researchers whose work shows the potential for groundbreaking contributions in their fields.

24 Sep 2016

Batavia Biosciences receives $8 million grant to develop safe, affordable rotavirus vaccine

Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market.

24 Sep 2016

KAUST researchers develop biocompatible nanostructures for use in gene delivery

A tiny therapeutic delivery system that can control the body’s ability to manufacture proteins has been developed by Saudi Arabia's King Abdullah University of Science and Technology (KAUST) researchers.

24 Sep 2016

Breakthrough research opens door to potential new therapies for inflammatory diseases

Scientists have made a major breakthrough in understanding the workings of the cellular machinery involved in a host of inflammatory diseases.

24 Sep 2016

Antibody drug offers new therapeutic approach for treating AML

An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia.

24 Sep 2016

DGIST researchers uncover mechanisms that control appetite during low glucose conditions in the brain

Researchers from Daegu Gyeongbuk Institute of Science and Technology (DGIST) in Korea have uncovered the mechanisms behind the enzyme that controls our appetite in response to low glucose availability in the brain.

24 Sep 2016

New global map shines light on genetic roots of diseases

A global genetic interaction map is revolutionizing how genes are being studied. A new study, involving University of Minnesota researchers, is no longer looking at genes as loners, but instead as a social network of the body, interacting in groups. The new approach may ultimately change our understanding of the genetic roots of diseases.

23 Sep 2016

Yale researchers compare efficacy of four PD-L1 assay tests

In a recent study, a Yale Cancer Center team compared the performance of the four available PD-L1 assay tests.

23 Sep 2016

Identical twins experience unimaginable cancer

Since the day they came home from the hospital in matching newborn monkey outfits, Zane and Zac Taylor have done everything together.

23 Sep 2016

T Cell News and Research

Latest T Cell News and Research

EVG brings high-volume manufacturing process solutions to biotechnology and medical device market

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Researchers identify new immune cell that protects mice from lung infections during chemotherapy

Nanoparticle injections may help prevent cartilage degeneration in osteoarthritis patients

Cross-disciplinary concepts may lead to effective, personalised cancer treatments

Increasing specific brain fats could be potential strategy for preventing epileptic seizures

Research shows degenerative diseases affecting the retina may be treatable with gene therapy

University of Bonn researchers develop new method to combat complex brain tumors

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

Salk scientist Clodagh O'Shea named recipient of grant from Faculty Scholars Program

Batavia Biosciences receives $8 million grant to develop safe, affordable rotavirus vaccine

KAUST researchers develop biocompatible nanostructures for use in gene delivery

Breakthrough research opens door to potential new therapies for inflammatory diseases

Antibody drug offers new therapeutic approach for treating AML

DGIST researchers uncover mechanisms that control appetite during low glucose conditions in the brain

New global map shines light on genetic roots of diseases

Yale researchers compare efficacy of four PD-L1 assay tests

Identical twins experience unimaginable cancer

Immunology eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Newsletters you may be interested in